Hello everyone! I’m here to share some exciting news from Sun Pharmaceutical Industries. Starting September 1, 2025, Kirti Ganorkar will take over as the Managing Director of the company. He’ll be stepping into the role previously held by the founder, Dilip Shanghvi.
Kirti has been with Sun Pharma since 1996 and has played a vital role in its growth. Since 2019, he has led the company’s India business, helping it expand and increase its market share. His experience spans various areas, including marketing, new product development, and international expansion. Notably, he was instrumental in Sun Pharma’s entry into Japan and laid the groundwork for its expansion into Europe.
Despite stepping down from the Managing Director role, Dilip Shanghvi will continue to serve as the Executive Chairman of the Board. This ensures that the company maintains a strong leadership foundation and continues its strategic growth
Kirti expressed his enthusiasm about this new chapter, stating that it’s been a rewarding journey to be part of Sun Pharma’s transformation into a leading global pharmaceutical enterprise. He looks forward to building on the strong foundation laid by Mr. Shanghvi and the global leadership team.
This leadership change is part of Sun Pharma’s well-planned succession strategy, aiming to ensure continuity and strengthen the company’s long-term vision.
It’s an exciting time for Sun Pharma, and we can look forward to seeing how Kirti’s leadership will shape the company’s future.